Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
The SURMOUNT-4 data shows that weight is generally maintained with ongoing use, but that discontinuing the medication without lifestyle support often results in weight returning
Note that there are drugs in development as sub-cutaneous (SC) administration (like current Ozempic, Wegovy, Zepbound, Mounjaro), whilst we wont need to wait to long for the oral versions of these drugs to come out (next 6-12 months)
A cosa serve
Start with the outcome you care about most: recovery, cognition, sleep, metabolic support, or healthy aging
Its antioxidant properties make it effective in neutralizing free radicals
The molecule is currently undergoing Phase 3 clinical trials, which are the final and most rigorous testing hurdle before a medication can be considered for public use
US$ 28.10
US$ 24.81
US$ 26.58
US$ 28.13
US$ 23.13
US$ 21.05
US$ 24.70
US$ 28.16
US$ 29.56
